Monday, May 8, 2023

< + > Small-Molecule Price Controls Are A Big Mistake

The Inflation Reduction Act's drug price controls may be popular. But by discouraging companies from investing in innovative, accessible drugs, they'll harm current and future patients in need of effective therapies.

No comments:

Post a Comment

< + > Weekly Roundup – June 27, 2026

Welcome to our Healthcare IT Today Weekly Roundup . Each week, we’ll be providing a look back at the articles we posted and why they’re impo...